Abstract
Mutations in the androgen receptor (AR) gene that impair hormone action lead to abnormal male sexual development. This study investigated nine patients with receptor-negative androgen resistance, where 5α-dihydrotestosterone (DHT) binding is absent despite a seemingly intact gene. Using PCR and sequence analysis, we identified a single nucleotide substitution (G to A) in exon 6 of one patient (N750). This mutation creates a premature termination codon at amino acid 794, resulting in a truncated, non-functional receptor protein.
Introduction
Androgen Insensitivity Syndrome (AIS) encompasses a spectrum of disorders where individuals with a 46,XY karyotype exhibit varying degrees of feminization due to defects in the androgen receptor. While some cases involve large gene deletions, many "receptor-negative" patients show no gross genomic alterations. This research aimed to pinpoint the subtle molecular defects responsible for complete androgen resistance in these individuals.
Genomic Integrity Across Patients
Initial analysis focused on determining if large-scale structural changes were present in the AR gene. Using labeled probes specific to each coding exon, the researchers performed Southern blotting on DNA from nine unrelated patients.
As shown in Figure 2, the hybridization patterns for exons 1 through 8 were identical across all patients and healthy controls. This confirmed that the resistance was not due to the absence of the gene or major rearrangements, suggesting instead that small-scale mutations were the likely cause.
Identification of a Premature Stop Codon
To find these subtle changes, the team amplified each exon using PCR and performed nucleotide sequencing. In patient N750, a critical "typo" was discovered in exon 6.
The sequence analysis (Figure 4) revealed a single guanosine to adenosine substitution. In the genetic code, this changes the codon for tryptophan (TGG) at position 794 into a premature termination codon (TGA). This "stop sign" occurs 122 amino acids before the natural end of the protein.
Functional Consequences
Despite the premature stop codon, S1 nuclease protection assays showed that AR mRNA levels in the patient's fibroblasts were normal. Furthermore, when the mutated cDNA was transfected into eukaryotic cells, a truncated protein was produced in normal amounts. However, this shortened receptor, missing a significant portion of its steroid-binding domain, was completely unable to bind DHT. Immunoblotting confirmed the mutant receptor was approximately 11 kD smaller than the normal 110 kD receptor, consistent with the loss of 122 amino acids.
Conclusion
The discovery of a single nucleotide substitution in patient N750 demonstrates that even the smallest genetic alteration can lead to complete androgen resistance. This study highlights the importance of high-resolution sequencing in diagnosing AIS and suggests that "receptor-negative" resistance is a genetically heterogeneous condition driven by various point mutations rather than a single common defect.
Summary updated